The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

David P. Steensma, Gordon W. Dewald, Terra L. Lasho, Heather L. Powell, Rebecca F. McClure, Ross L. Levine, D. Gary Gilliland, Ayalew Tefferi

Research output: Contribution to journal › Article › peer-review

397 Scopus citations

Fingerprint

Dive into the research topics of 'The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds